Generate Biomedicines, Inc. Common Stock — États financiers trimestriels (NASDAQ:GENB)

Afficher le graphique complet Full chart

Financials

Aperçu Relevé Statistiques

Trimestriel Annuel

Market Capitalization 1.6909 B
Employee 312
Founded 2018
CEO N/A
Website www.generatebiomedicines.com
Headquarter Delaware, United States
FIGI BBG00X9D0NZ0
Industry Fabricants de Médicaments — Généralités

Chiffre d'affaires total

Résultat net

Bénéfice par action de base (BPA de base)

Dette totale

Flux de trésorerie disponible

Trésorerie et équivalents de trésorerie

Generate Biomedicines, Inc. - Common Stock

Generate:Biomedicines is a biotechnology company founded in 2018 and headquartered in Somerville, Massachusetts. It specializes in using machine learning to design and optimize proteins for therapeutic applications, with a focus on immunology, oncology, and infectious diseases.